Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,943 INR | -0.24% | -2.32% | +2.50% |
Apr. 19 | Dr. Reddy's Labortories Launches Care Plan for IBS Patients | MT |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Evolution of the average Target Price on Dr. Reddy's Laboratories Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Dr. Reddy's Laboratories Limited
Barclays | |
Jefferies & Co. | |
Nomura |
EPS Revisions
- Stock Market
- Equities
- 500124 Stock
- DRREDDY Stock
- Consensus Dr. Reddy's Laboratories Limited